IRIDICA: Transforming Infectious Disease Diagnostics for Critically Ill Patients

In this exclusive interview, Deepak Nath, President of Abbott Molecular, introduces the brand new IRIDICA system for diagnosing infectious disease. This state-of-the-art system, currently under development and based on mass spectrometry technology, has the potential to change the way that physicians diagnose serious infections.